Analytical Data
-
基因名
BCAS3
- Application
-
别名
GAOB1; MAAB; GAOB1
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9H6U6
-
表达区间
Met230~Gly546
-
分子量
42kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BCAS3 (Breast Cancer Amplified Sequence 3) is a gene that has garnered significant interest due to its potential role in cancer biology, particularly in breast cancer. Initially identified as an amplified sequence in breast cancer tissues, BCAS3 is believed to contribute to tumor progression and metastasis. Research has shown that BCAS3 is overexpressed in various cancer types, which points to its involvement as a potential oncogene. Moreover, studies suggest that BCAS3 may play a role in modulating cell growth, survival, and invasive properties, highlighting its significance in cancer development and therapeutic resistance. The creation of recombinant BCAS3 protein allows for detailed functional studies, enabling researchers to elucidate its biological mechanisms and interactions within cellular pathways. This understanding could lead to the identification of novel diagnostic markers or therapeutic targets, fostering advancements in personalized medicine approaches for breast and other cancers. The ongoing exploration of BCAS3's roles in cancer also emphasizes the need for targeted research to develop effective strategies to inhibit its function in malignancies, providing hope for improved treatment options for patients.
